期刊文献+

2型糖尿病患者血浆总同型半胱氨酸水平变化及其与糖尿病血管并发症之间的关系 被引量:3

Changes of Plasma Total Homocysteine in Type Ⅱ Diabetic Patients Its Association with Diabetic Vascular Complications
下载PDF
导出
摘要 目的研究正常糖耐量(NGT)人群和2型糖尿病(T2DM)患者血浆总同型半胱氨酸(total homocysteine,tHcy)水平,探讨影响血浆tHcy水平的因素以及T2DM患者血浆tHcy与糖尿病血管并发症之间的关系。方法纳入研究对象135例(其中NGT 55例、T2DM患者80例),检测其空腹血浆tHcy水平,同时测量受试者身高、体质量、腰围(WC)、臀围、血压,并计算体重指数(BMI)和腰臀比(WHR);测定血脂、空腹及服糖后0.5h、1 h、2 h血糖和胰岛素,并计算葡萄糖(AUCGlu)与胰岛素(AUCIns)曲线下面积、HOMA胰岛素抵抗指数(HOMA-IR)。结果T2DM组平均血浆tHcy水平〔(21.09±10.99)μmol/L〕显著高于NGT组〔(3.70±5.54)μmol/L〕(P=0.000);AUCGlu和WC是影响血浆tHcy水平的重要危险因素(调整后R2=0.378,P=0.000);血浆tHcy水平(OR=1.109)和年龄(OR=1.146)是T2DM患者周围动脉血管病变发生的重要危险因素。结论T2DM患者血浆tHcy水平明显高于NGT人群;血糖和WC是影响血浆tHcy水平的重要危险因素;血浆tHcy水平升高是导致T2DM患者周围动脉血管病变的独立危险因素。 Objective To identify the differences and contributing factors of plasma total homocysteine (tHey) in people with type Ⅱ diabetes mellitus(T2DM) and people who had normal glucose tolerance (NGT) ; and to explore the association between plasma they and diabetic vascular complications. Methods One hundred and thirty-five people ( fifty-five in NGT group, eighty in T2DM group) were enrolled in this cross sectional study. The height, weight, waist circumference, hip circumference, and blood pressure of the participants were measured. The body mass index (BMI) and waist-hip ratio (WHR) were calculated. The fasting plasma tHey, serum vitamin B12, and plasma folio acid were determined. Oral glucose tolerance test and insulin releasing test were performed to assess insulin secretion area under the curve (AUC) and insulin Sensitivity (HOMA-IR), Lipid profiles were also assessed at the same time. Results T2DM patients had significantly higher plasma tHey [(21. 09±10.99) μmol/L] than the people in the NGT group [(3.70±5.54)μmol/L, P=0. 000]. The stepwise multiple regression analysis showed that LnAUCGlu and WC were independent contributors to the increase of plasma tHey (adjusting R^2= 0. 378, P= 0. 000). The logistic regression analysis showed that tHey (OR= 1. 109) and age (OR = 1. 146) were associated with diabetic macroangiopathy. Conclusion Plasma they increase in patients with type Ⅱ diabetes. Glucose and WC are important contributors to the increase of plasma tHey in T2DM patients. The increase of plasma they contributes to diabetic macroangiopathy.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2008年第6期980-984,共5页 Journal of Sichuan University(Medical Sciences)
关键词 2型糖尿病 正常糖耐量 血浆总同型半胱氨酸 糖尿病血管并发症 Type 2 diabetes vascular complications Normal glucose tolerance Plasma total homocysteine Diabetic
  • 相关文献

参考文献21

  • 1Fortin L J, Genest J Jr. Measurement of homocyst(e)ine in the prediction of arteriosclerosis. Clin Biochem, 1995; 28(2) :155- 162.
  • 2Araki A, Sako Y, Ito H. Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus: effect of parenteral methylcobalamin treatment. Atherosclerosis, 1993 ; 103 (2) : 149-157.
  • 3Hofmann MA, Kohl B, Zumbach MS, et al. Hyperhomocyst (e) inemia and endothelial dysfunction in IDDM. Diabetes Care,1998;21(5):841-848.
  • 4World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation. Part 1 : Diagnosis and Classification of Diabetes Mellitus. Geneva,WHO, 1999.
  • 5潘长玉,高妍,袁申元,李光伟,王姮,陆菊明,李俊来,杨国庆,张俊清,陈铭,朱良湘,刘效慈,肖平,张学文,肖新华,李文慧,姜育新.2型糖尿病下肢血管病变发生率及相关因素调查[J].中国糖尿病杂志,2001,9(6):323-326. 被引量:509
  • 6Gross JL, de Azevedo M J, Silveiro SP. et al. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care,2005 ; 28(1) : 164-176.
  • 7Soonthornpun S, Setasuban W, Thamprasit A, et al. Novel insulin sensitivity index derived from oral glucose tolerance test. J Clin Endocrinol Metab, 2003 ; 88 (3) : 1019-23.
  • 8Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985 ; 28 ( 7 ) : 412-419.
  • 9Katsuki A, Sumida Y, Urakawa H, et al. Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance. Diabetes Care,2003;26 (8) : 2341-2344.
  • 10冉兴无,李晓松,童南伟,李启富,汤保德,李秀钧.应用简易体脂参数估测中国肥胖人群腹腔内及腹壁皮下脂肪面积[J].四川大学学报(医学版),2003,34(3):519-522. 被引量:19

二级参考文献21

  • 1贾伟平,项坤三,丁炜,陆俊茜.男性中国人体脂分布与激素模式[J].中华内分泌代谢杂志,1998,14(2):78-81. 被引量:20
  • 2贾伟平,项坤三,吴松华,杨世埙,潘晓平,王延庆,何进卫,唐峻岭,严钱勤,薛凤仙,翁青.腹内型肥胖的代谢特点及合并NIDDM后的变化[J].中国糖尿病杂志,1995,3(1):11-14. 被引量:31
  • 3[1]Amos AF, McCarty PJ, Zimmet P. The rising global burden of diabetes and its complications. Estimates and projections to the year 2010,Diab Med,1997,7:85.
  • 4[4]Diabetes Drafting Group. Prevalence of small vessel and large vessel disease in diabetic patients from 14 centers:The world health organization multinational study of vascular disease in diabetics. Diabetologia. 1985,28:615~640.
  • 5WHO/NUT/NCD. Obesity: Preventing and managing the global epidemic. Report of a WHO consultation on obesity.Gneva: WHO, 1997:3.
  • 6Smith SR, Lovejoy JC, Greenway F, et al. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metabolism, 2001; 50(4) :425.
  • 7Matsuura F, Yamashita S, Nakamura T, et al. Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity.Metabolism, 19981 47(8):929.
  • 8Nakamura T, Tokunaga K, Shimomura I, et al. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis, 1994;107(2),239.
  • 9Nguyen-Duy TB, Nichaman MZ, Church TS, et al. Visceral fat and liver fat are independent predictors of metabolic risk(actors in men. Am J Physiol Endocrinol Metab, 2003;284(6) :E1065.
  • 10Nieves DJ, Cnop M, Retzlaff B, et al. The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes, 2003;52(1):172.

共引文献743

同被引文献28

  • 1吴伽,蔡爱玲.糖尿病合并微血管病变患者血细胞体积改变及其临床意义[J].微循环学杂志,2004,14(3):91-91. 被引量:2
  • 2徐黔宁.糖尿病患者红细胞平均体积和血小板各参数的临床意义[J].江西医学检验,2004,22(4):337-338. 被引量:13
  • 3Heng Guan,Yong-jun Li,Zhang-rong XU,Guang-wei Li,Xiao-hui Guo,Zhi-min Liu,Da-jin Zou,Hui-li Xing,Wei Liu,Zheng-yan Sheng,Hao-ming Tian,Da-long Zhu,De-min YU,Wei-te Zhuang,Lu-lu Chen,Jian-ping Weng.PREVALENCE AND RISK FACTORS OF PERIPHERAL ARTERIAL DISEASE IN DIABETIC PATIENTS OVER 50 YEARS OLD IN CHINA[J].Chinese Medical Sciences Journal,2007,22(2):83-88. 被引量:41
  • 4Austin R C, Lentz S R, Werstuck G H. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease [ J ]. Cell Death Differ, 2004,11 ( Suppl 1 ) :S56-S64.
  • 5I Wood D. Established and emerging cardiovascular risk factors [ J ]. Am Heart J, 2001,141 (2 Suppl) : $49-$57.
  • 6Sun Y, Chien KL, Hsu HC, et al. Use of serum homocysteine to predict stroke, coronary heart disease and death in ethnic Chinese. 12-year prospective cohort study[ J]. Circ J ,2009,73 ( 8 ) : 1423- 1430.
  • 7Emoto M, Kanda H, Shoji T, et al. Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes[J].Diabetes Care,2001,24 (3) :533-538.
  • 8Shams N, Ianchulev T. Role of vascular endothelial growth factor in ocular angiogenesis[J].Ophthalmol Clin North Am, 2006,19 (3) :335-344.
  • 9Petrovic MG, Korosec P, Kosnik M, et al. Local and genetic de- terminants of vascular endothelial growth factor expression in ad- vanced proliferative diabetic retinopathy [ J ]. Mol Vis, 2008,14 : 1382-1387.
  • 10Atta HM, E1-Rehani MA, Rabeim SA, et al. Lowering homocys- teine deereases levels and expression of VEGF( 165 ) and endosta- tin[J]. J Surg Res,2008 ,146(2) :202-210.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部